CHRM2 and neuroblastoma: The role of M2 muscarinic receptors has been largely investigated by our group in recent years, demonstrating its ability to inhibit cell proliferation and survival in primary glioblastoma cell lines [37,38,39,40,41,42] as well as in neuroblastoma [43].